← Back to Search

Other

Sunflower Lecithin for Meibomian Gland Dysfunction

N/A
Waitlist Available
Research Sponsored by George Washington University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days

Summary

This trial is testing if sunflower lecithin capsules can help adults with dry eye disease by improving their meibomian gland function. Participants will take these capsules daily for a few months, and their eye dryness will be measured before and after the treatment.

Eligible Conditions
  • Meibomian Gland Dysfunction
  • Dry Eye Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change from Baseline of the SPEED questionnaire score at Day 90
Secondary study objectives
Change from Baseline of Fluorescein Tear Break-Up Time (Seconds) at Day 90
Change in number of MMP-positive eyes at Day 90
Least Squares Mean Change from Baseline in Meibomian Gland Score (MGS) at Day 90

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Sunflower LecithinExperimental Treatment1 Intervention
Total 4800 mg sunflower lecithin per day taken in 4 softgel capsules
Group II: Olive OilPlacebo Group1 Intervention
Total 4000 mg olive oil per day taken in 4 softgel capsules
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sunflower lecithin
2023
N/A
~40

Find a Location

Who is running the clinical trial?

Virginia Lions Institute FoundationUNKNOWN
George Washington UniversityLead Sponsor
254 Previous Clinical Trials
466,559 Total Patients Enrolled
1 Trials studying Meibomian Gland Dysfunction
50 Patients Enrolled for Meibomian Gland Dysfunction
David Belyea, MDStudy ChairThe George Washington University
1 Previous Clinical Trials
81 Total Patients Enrolled
~13 spots leftby Nov 2025